| Cash Flow | 2025-09-30 |
|---|---|
| Net income | 608,496 |
| Provision for (reversal of) credit losses | 35,855 |
| Depreciation, amortization, and accretion, net | 41,795 |
| Deferred income tax expense (benefit) | 8,100 |
| Originations of loans held for sale | 5,760,855 |
| Proceeds from sales and payments on loans held for sale | 5,712,111 |
| Gain on sales of loans held for sale, net | 9,236 |
| (increase) decrease in other assets | -138,363 |
| Increase (decrease) in other liabilities | -354,615 |
| Investment securities (gains) losses, net | 1,742 |
| Share-based compensation expense | 23,649 |
| Net gain on sales of other real estate and other assets held for sale | 1,066 |
| Net cash provided by (used in) operating activities | 440,855 |
| Proceeds from maturities and principal collections of investment securities held to maturity | 180,373 |
| Proceeds from maturities and principal collections of investment securities available for sale | 424,674 |
| Proceeds from sales of investment securities available for sale | 173,996 |
| Purchases of investment securities available for sale | 366,836 |
| Net proceeds from sales of loans | 14,379 |
| Net (increase) decrease in loans | 1,227,629 |
| Net (purchases) redemptions of federal home loan bank stock | 76,271 |
| Net (purchases) redemptions of federal reserve bank stock | 315 |
| Net proceeds from settlement (purchases) of bank-owned life insurance policies | 11,766 |
| Net increase in premises, equipment and software | 21,760 |
| Proceeds from sales of other real estate and other assets held for sale | 4,374 |
| Net cash provided by (used in) investing activities | -883,249 |
| Net increase (decrease) in deposits | -1,104,275 |
| Net increase (decrease) in federal funds purchased, securities sold under repurchase agreements, and other short-term borrowings | -69,261 |
| Repayments and redemption of long-term debt | 900,000 |
| Proceeds from long-term debt, net | 2,150,000 |
| Dividends paid to common shareholders | 162,517 |
| Dividends paid to preferred shareholders | 34,122 |
| Repurchases of common stock | 142,269 |
| Issuances, net of taxes paid, under equity compensation plans | -14,942 |
| Net cash provided by (used in) financing activities | -277,386 |
| Increase (decrease) in cash and cash equivalents including restricted cash | -719,780 |
| Cash and cash equivalents at beginning of period | 2,993,987 |
| Cash and cash equivalents at end of period | 2,274,207 |
SYNOVUS FINANCIAL CORP (SNV-PE)
SYNOVUS FINANCIAL CORP (SNV-PE)